{"name": "Aileron Therapeutic",
 "permalink": "aileron-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/aileron-therapeutics",
 "homepage_url": "http://www.aileronrx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2005,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@aileronrx.com",
 "phone_number": "617-995-0900",
 "description": "biotechnology company",
 "created_at": "Tue Jun 16 06:18:35 UTC 2009",
 "updated_at": "Mon Mar 25 10:19:40 UTC 2013",
 "overview": "\u003Cp\u003EAileron Therapeutics, based in Cambridge, Massachusetts, is a biopharmaceutical company that was founded in 2005 to develop and advance a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution, or \u0026#8220;scaffold\u0026#8221; for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The ability to target and regulate these control points affords the unique opportunity to exploit potentially thousands of currently \u0026#8220;undruggable\u0026#8221; cellular targets with applications in all human diseases.\u003C/p\u003E\n\n\u003Cp\u003EAileron\u00e2\u20ac\u2122s proprietary technology locks peptides into their biologically active shape, mimicking the structures found in nature, and ultimately endows the peptide with unique properties, including efficient cell penetration, high affinity binding to large target protein surfaces and excellent stability within the body.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       87],
      "assets/images/resized/0004/8789/48789v1-max-150x150.png"],
     [[153,
       89],
      "assets/images/resized/0004/8789/48789v1-max-250x250.png"],
     [[153,
       89],
      "assets/images/resized/0004/8789/48789v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Joseph",
      "last_name": "A. Yanchik III",
      "permalink": "joseph-a-yanchik-iii",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$69.5M",
 "funding_rounds":
  [{"round_code": "d",
    "source_url": "http://www.zibb.com/article/5328061/Aileron+Therapeutics+Closes+Series+D+Financing?expired=4556347",
    "source_description": "Aileron Therapeutics Closes Series D Financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 6,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Excel Medical Ventures",
         "permalink": "excel-medical-fund",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/8807/48807v1-max-150x150.jpg"],
             [[250,
               33],
              "assets/images/resized/0004/8807/48807v1-max-250x250.jpg"],
             [[386,
               52],
              "assets/images/resized/0004/8807/48807v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Roche Venture Fund",
         "permalink": "roche-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://boston.bizjournals.com/boston/stories/2008/04/28/story10.html",
    "source_description": "Aileron ramps up business on heels of positive results",
    "raised_amount": 10500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 4,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/aileron-scores-7m-in-new-venture-funds/2007-06-06",
    "source_description": "Aileron scores $7M in new venture funds",
    "raised_amount": 7000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 12,
    "funded_day": 1,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.finsmes.com/2013/01/aileron-therapeutics-raises-12m-series-financing.html",
    "source_description": "Aileron Therapeutics Raises $12M in Series D Financing",
    "raised_amount": 12000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 1,
    "funded_day": 14,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Apple Tree Partners",
         "permalink": "apple-tree-partners",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/8810/48810v2-max-150x150.png"],
             [[250,
               35],
              "assets/images/resized/0004/8810/48810v2-max-250x250.png"],
             [[318,
               45],
              "assets/images/resized/0004/8810/48810v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Excel Venture Management",
         "permalink": "excel-venture-management",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0010/1993/101993v1-max-150x150.jpg"],
             [[250,
               29],
              "assets/images/resized/0010/1993/101993v1-max-250x250.jpg"],
             [[450,
               52],
              "assets/images/resized/0010/1993/101993v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lilly Ventures",
         "permalink": "lilly-ventures",
         "image":
          {"available_sizes":
            [[[150,
               71],
              "assets/images/resized/0005/5135/55135v3-max-150x150.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-250x250.png"],
             [[240,
               114],
              "assets/images/resized/0005/5135/55135v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Roche Venture Fund",
         "permalink": "roche-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               21],
              "assets/images/resized/0004/6088/46088v1-max-150x150.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-250x250.jpg"],
             [[156,
               22],
              "assets/images/resized/0004/6088/46088v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "HQ",
    "address1": "840 Memorial Drive, 2nd Floor",
    "address2": "Cambridge",
    "zip_code": "MA 02139",
    "city": "",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": 42.101977,
    "longitude": -72.637994}],
 "milestones":
  [{"description": "New Roche deal could net Aileron $1.1B",
    "stoned_year": 2010,
    "stoned_month": 8,
    "stoned_day": 24,
    "source_url": "http://www.masshightech.com/stories/2010/08/23/daily13-New-Roche-deal-could-net-Aileron-11B.html",
    "source_text": "",
    "source_description": "New Roche deal could net Aileron $1.1B",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Aileron Therapeutic",
      "permalink": "aileron-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        137],
       "assets/images/resized/0004/8792/48792v1-max-150x150.jpg"],
      [[250,
        228],
       "assets/images/resized/0004/8792/48792v1-max-250x250.jpg"],
      [[450,
        411],
       "assets/images/resized/0004/8792/48792v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}